Please use this identifier to cite or link to this item:
http://hdl.handle.net/11375/27983
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.advisor | Pond, Gregory | - |
dc.contributor.author | Febbraro, Michela | - |
dc.date.accessioned | 2022-10-12T15:34:31Z | - |
dc.date.available | 2022-10-12T15:34:31Z | - |
dc.date.issued | 2022 | - |
dc.identifier.uri | http://hdl.handle.net/11375/27983 | - |
dc.description.abstract | Background: There is no standardized approach to clinical trial education for Canadian medical oncology subspecialty training. Canadian medical oncology subspecialty training programs have transitioned to a competency by design (CBD) educational framework. This study aims to determine whether current education practices in medical oncology subspecialty training programs in Canada prepare medical oncology trainees for participating in clinical trials as an investigator. Methods: A national, online, bi-lingual questionnaire to understand exposure to clinical trials and general research in training, self-perceived competence, preparedness, and willingness to participate in clinical trials was conducted. Participants included medical oncology resident trainees and fellow trainees and new-to-practice physicians who have practiced in medical oncology for less than 5 years. All participants had to complete a medical oncology subspecialty training program in Canada. Data were collected from November 2021 to February 2022. Results are presented using descriptive statistics. Results: Out of the 41 respondents (response rate: 15%), most were new physicians (41%), from Ontario (61%). 73% did not have formal training on how to participate in clinical trials as an investigator. 65% rated their competence in clinical trials as fair/poor and 74% rated their preparedness for clinical trials as fair/poor after training. 79% were willing to participate as an investigator in clinical trials after training. A correlation analysis revealed structured or in-clinic teaching in clinical trials trended towards improved self-evaluations of competence, preparedness, and willingness to participate in clinical trials (p > 0.05). Most respondents (56%) sought additional clinical trial education after training. Conclusion: Training in clinical trials is highly variable. After training, most trainees do not feel competent or prepared to participate in clinical trials as an investigator, but they have a willingness to pursue clinical trials. Further assessment into how to produce competent medical oncology clinical trial investigators is warranted. | en_US |
dc.language.iso | en | en_US |
dc.subject | Education | en_US |
dc.subject | CBME | en_US |
dc.subject | Medical Education | en_US |
dc.subject | Medicine | en_US |
dc.subject | Residency | en_US |
dc.subject | Medical Oncology | en_US |
dc.title | Preparedness for Clinical Trials in Medical Oncology Subspecialty Training in Canada - A National, Bi-Lingual Questionnaire | en_US |
dc.type | Thesis | en_US |
dc.contributor.department | Health Research Methodology | en_US |
dc.description.degreetype | Thesis | en_US |
dc.description.degree | Master of Health Sciences (MSc) | en_US |
dc.description.layabstract | Clinical trials are pivotal in the field of medical oncology, leading to the changing diagnostic and treatment landscape in medical oncology. Knowledge of how to participate in clinical trials as an investigator is becoming increasingly important in the field of medical oncology. Early integration of clinical trial experiences can increase early-career physician participation. This study assessed current teaching practices related to clinical trial education in medical oncology subspecialty training programs in Canada. Self-assessments of competence and preparedness to participate in clinical trials after training were low, while self-assessment of willingness to participate was high. In-clinic training trended towards improved self-assessments of competence and preparedness. An approach to medical education that increases in-clinic exposure to clinical trials in the subspecialty curriculum is needed to improve preparedness and competence in clinical trials after medical oncology subspecialty training. | en_US |
Appears in Collections: | Open Access Dissertations and Theses |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
HRM Thesis - M.Febbraro - 001368256.pdf | 628.84 kB | Adobe PDF | View/Open |
Items in MacSphere are protected by copyright, with all rights reserved, unless otherwise indicated.